Boston Scientific Corporation (BSX)
Largest Insider Buys in Sector
BSX Stock Price History Chart
BSX Stock Performance
About Boston Scientific Corporation
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and …
Insider Activity of Boston Scientific Corporation
Over the last 12 months, insiders at Boston Scientific Corporation have bought $0 and sold $96.98M worth of Boston Scientific Corporation stock.
On average, over the past 5 years, insiders at Boston Scientific Corporation have bought $2.1M and sold $75.38M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 50,000 shares for transaction amount of $2.1M was made by WICHMANN DAVID S (director) on 2021‑11‑15.
List of Insider Buy and Sell Transactions, Boston Scientific Corporation
| 2024-12-02 | Sale | EVP, Human Resources | 6,983 0.0005% | $90.78 | $633,917 | -0.01% | ||
| 2024-11-27 | Sale | SVP, Global Controller and CAO | 1,336 <0.0001% | $90.65 | $121,105 | -0.35% | ||
| 2024-11-25 | Sale | EVP& Grp Pres, MedSurg & APAC | 14,010 0.001% | $89.27 | $1.25M | +1.32% | ||
| 2024-11-21 | Sale | director | 4,877 0.0003% | $91.63 | $446,902 | -1.18% | ||
| 2024-11-08 | Sale | EVP, Global Operations | 30,580 0.0021% | $87.66 | $2.68M | +2.21% | ||
| 2024-11-05 | Sale | Chairman, President & CEO | 162,778 0.0111% | $84.75 | $13.79M | +0.25% | ||
| 2024-11-01 | Sale | EVP, Human Resources | 6,983 0.0005% | $84.33 | $588,876 | +7.76% | ||
| 2024-10-07 | Sale | Chairman, President & CEO | 162,777 0.0113% | $84.63 | $13.78M | +5.11% | ||
| 2024-10-07 | Sale | EVP & Group Pres, Cardiology | 132,527 0.0092% | $85.00 | $11.26M | +5.11% | ||
| 2024-10-01 | Sale | EVP, Human Resources | 6,983 0.0005% | $83.86 | $585,594 | +5.16% | ||
| 2024-09-05 | Sale | Chairman, President & CEO | 162,777 0.011% | $81.17 | $13.21M | +6.91% | ||
| 2024-09-03 | Sale | EVP, Human Resources | 6,983 0.0005% | $81.70 | $570,511 | +7.07% | ||
| 2024-08-28 | Sale | EVP & Group Pres, Cardiology | 14,132 0.001% | $80.00 | $1.13M | +9.07% | ||
| 2024-08-26 | Sale | EVP& Grp Pres, MedSurg & APAC | 14,012 0.0009% | $79.25 | $1.11M | +8.93% | ||
| 2024-08-01 | Sale | EVP, Human Resources | 6,983 0.0005% | $74.12 | $517,580 | +12.48% | ||
| 2024-07-01 | Sale | EVP, Human Resources | 6,983 0.0005% | $77.30 | $539,786 | 0.00% | ||
| 2024-06-03 | Sale | EVP, Human Resources | 6,983 0.0005% | $75.33 | $526,029 | +10.65% | ||
| 2024-05-29 | Sale | EVP&Pres, Periph Intervent | 63,802 0.0043% | $75.10 | $4.79M | +11.16% | ||
| 2024-05-28 | Sale | EVP& Grp Pres, MedSurg & APAC | 14,011 0.001% | $75.34 | $1.06M | +10.84% | ||
| 2024-05-23 | Sale | EVP and CFO | 47,621 0.0033% | $75.11 | $3.58M | +11.84% |
Insider Historical Profitability
| Mahoney Michael F | Chairman, President & CEO | 1521205 0.1032% | $91.07 | 2 | 25 | +37.05% |
| LUDWIG EDWARD J | director | 39398 0.0027% | $91.07 | 1 | 3 | +26.95% |
| Dockendorff Charles J | director | 0 0% | $91.07 | 1 | 2 | +35.4% |
| ABELE JOHN E | Director Emeritus | 500000 0.0339% | $91.07 | 5 | 212 | +7.41% |
| BEST LAWRENCE C | EVP | 232189 0.0158% | $91.07 | 1 | 24 | <0.0001% |
Institutional Investor Ownership
| Fidelity Investments | $9.72B | 9.65 | 141.93M | +2.66% | +$251.98M | 0.65 | |
| The Vanguard Group | $8.73B | 8.67 | 127.44M | +1.58% | +$136.16M | 0.16 | |
| BlackRock | $8.69B | 8.63 | 126.84M | +0.22% | +$18.9M | 0.19 | |
| State Street | $4.3B | 4.27 | 62.73M | +0.63% | +$26.96M | 0.18 | |
| Massachusetts Financial Services Co Ma | $3.19B | 3.17 | 46.61M | -18.48% | -$723.87M | 0.95 |